Carson Allaria Wealth Management, Ltd. Ocuphire Pharma, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $167 Million
- Q1 2025
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 1,000 shares of OCUP stock, worth $980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$980
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
53Shares Held
14.6MCall Options Held
13.7KPut Options Held
1K-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.18% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.16MShares$3.09 Million0.14% of portfolio
-
Opaleye Management Inc. Boston, MA1.18MShares$1.15 Million0.32% of portfolio
-
Bios Capital Management, LP Fort Worth, TX995KShares$975,3441.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...